Sequential bilateral transplantation in Parkinson's disease. Effects of the second graft

Brain

Volumn 122, Issue 6, 1999, Pages 1121-1132

  Hagell, P ^a   Schrag, A ^c   Piccini, P ^e   Jahanshahi, M ^d   Brown, R ^d   Rehncrona, S ^a   Widner, H ^a   Brundin, P ^a   Rothwell, J C ^d   Odin, P ^a   Wenning, G K ^c   Morrish, P ^e   Gustavii, B ^b   Bjorklund A ^a   Brooks, D J ^e   Marsden, C D ^c,d   Quinn, N P ^c   Lindvall, Olle ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Dopamine; Neural grafting; Parkinson's disease; Positron emission tomography; Striatum

Indexed keywords

DOPA; FLUORINE 18; LEVODOPA;

ADULT; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CLINICAL TRIAL; CORPUS STRIATUM; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; MALE; MESENCEPHALON; NERVE GRAFT; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN;

EID: 0032692348     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.6.1121     Document Type: Article

References (32)

1. Björklund L, Spenger C, Strömberg I. Tirilazad mesylate increases dopaminergic neuronal survival in the in oculo grafting model. Exp Neurol 1997; 148: 324-33.
2. Deacon T, Schumacher J, Dinsmore J, Thomas C, Palmer P, Kott S, et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 1997; 3: 350-3.
3. Defer GL, Geny C, Ricolfi F, Fenelon G, Monfort JC, Remy P, et al. Long-term outcome of unilaterally transplanted parkinsonian patients: I. Clinical approach. Brain 1996; 119: 41-50.
4. Duan WM, Widner H, Björklund A, Brundin P. Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: will the second graft be rejected? Neuroscience 1993; 57: 261-74.
5. Freeman TB, Olanow CW, Hauser RA, Nauert GM, Smith DA, Borlongan CV, et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 1995; 38: 379-88.
6. Frodl EM, Nakao N, Brundin P. Lazaroids improve the survival of cultured rat embryonic mesencephalic neurones. Neuroreport 1994; 5: 2393-6.
7. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. [Review]. J Neurol Neurosurg Psychiatry 1988; 51: 745-52.
8. Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJ, Mufson EJ, Sanberg PR, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease [see comments]. N Engl J Med 1995; 332: 1118-24. Comment in: N Engl J Med 1995; 332: 1163-4, Comment in: N Engl J Med 1995; 333: 730-1.
9. Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJ, Mufson EJ, Sanberg PR, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease [see comments]. N Engl J Med 1995; 332: 1118-24. Comment in: N Engl J Med 1995; 332: 1163-4, Comment in: N Engl J Med 1995; 333: 730-1.
10. Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJ, Mufson EJ, Sanberg PR, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease [see comments]. N Engl J Med 1995; 332: 1118-24. Comment in: N Engl J Med 1995; 332: 1163-4, Comment in: N Engl J Med 1995; 333: 730-1.
11. Kordower JH, Rosenstein JM, Collier TJ, Burke MA, Chen EY, Li JM, et al. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol 1996; 370: 203-30.
12. Kordower JH, Styren S, Clarke M, DeKosky T, Olanow CW, Freeman TB. Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants. Cell Transplant 1997; 6: 213-19.
13. Kordower JH, Freeman TB, Chen EY, Mufson EJ, Sanberg PR, Hauser RA, et al. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov Disord 1998; 13: 383-93.
14. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992; 7: 2-13.
15. Lindvall O, Rehncrona S, Brundin P, Gustavii B, Åstedt B, Widner H, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease: a detailed account of methodology and a 6-month follow-up. Arch Neurol 1989; 46: 615-31.
16. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease [see comments]. Science 1990; 247: 574-77. Comment in: Science 1990; 247: 529.
17. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease [see comments]. Science 1990; 247: 574-77. Comment in: Science 1990; 247: 529.
18. Lindvall O, Widner H, Rehncrona S, Brundin P, Odin P, Gustavii B, et al. Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol 1992; 31: 155-65.
19. Lindvall O, Sawle G, Widner H, Rothwell JC, Björklund A, Brooks D, et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 1994; 35: 172-80.
20. 18F]dopa PET. J Neurol Neurosurg Psychiatry 1998; 64: 314-9.
21. Nakao N, Frodl EM, Duan WM, Widner H. Brundin P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc Natl Acad Sci USA 1994; 91: 12408-12.
22. Othberg A, Keep M, Brundin P, Lindvall O. Tirilazad mesylate improves survival of rat and human embryonic mesencephalic neurons in vitro. Exp Neurol 1997; 147: 498-502.
23. Peschanski M, Defer G, N'Guyen JP, Ricolfi F, Monfort JC, Remy P, et al. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 1994; 177: 487-99.
24. Rehncrona S. A critical review of the current status and possible developments in brain transplantation. [Review]. Adv Tech Stand Neurosurg 1997; 23: 3-46.
25. 18F] fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 1995; 38: 580-8.
26. 18F]-6-L-fluorodopa studies in two patients with putaminal implants. Ann Neurol 1992; 31: 166-73.
27. Schierle GS, Hansson O, Leist M, Nicotera P, Widner H, Brundin P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat Med 1999; 5: 97-100.
28. Studer L, Tabar V, McKay RDG. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1998; 1: 290-5.
29. Wenning GK, Odin P, Morrish P, Rehncrona S, Widner H, Brundin P, et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997; 42: 95-107.
30. Widner H, Brundin P. Sequential intracerebral transplantation of allogeneic and syngeneic fetal dopamine-rich neuronal tissue in adult rats: will the first graft be rejected? Cell Transplant 1993; 2: 307-17.
31. Widner H, Tetrud J, Rehncrona S, Snow B, Brundin P, Gustavii B, et al. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [see comments]. N Engl J Med 1992; 327: 1556-63. Comment in: N Engl J Med 1992; 327: 1589-92
32. Widner H, Tetrud J, Rehncrona S, Snow B, Brundin P, Gustavii B, et al. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [see comments]. N Engl J Med 1992; 327: 1556-63. Comment in: N Engl J Med 1992; 327: 1589-92